Abstract
1. The effects of oral and subcutaneous administration of the non-steroidal anti-inflammatory drugs sodium salicylate, aspirin and indomethacin on ex vivo gastric mucosal release of leukotriene C4 (LTC4) prostaglandin E2 (PGE2), 6-oxo-PGF1 alpha and thromboxane B2 (TXB2) were investigated in rats under basal conditions as well as after challenge with ethanol. 2. Basal release of PGE2, 6-oxo-PGF1 alpha and TXB2 was inhibited by oral administration of aspirin (0.6-400 mgkg-1) and indomethacin (4 or 20 mgkg-1), but not by sodium salicylate (up to 400 mgkg-1), in a dose-dependent manner. Oral administration of aspirin in the dose range 3.2-400 mgkg-1 and of indomethacin (20 mgkg-1) additionally inhibited release of LTC4, while sodium salicylate (up to 400 mgkg-1) had no effect. Indomethacin (20 mgkg-1) and aspirin (400 mgkg-1) administered subcutaneously inhibited generation of cyclo-oxygenase products of arachidonate metabolism, but did not significantly affect LTC4 synthesis. 3. Oral instillation of ethanol caused gastric mucosal damage and simultaneously induced a selective increase in the ex vivo release of LTC4 from rat gastric mucosa, while release of cyclo-oxygenase products of arachidonate metabolism was not significantly affected. Oral pretreatment of rats with sodium salicylate protected the gastric mucosa and simultaneously inhibited the ethanol-stimulated gastric mucosal LTC4 release in a dose-dependent manner. Sodium salicylate had no effects on the release of PGE2 and TXB2, while that of 6-oxo-PGF1 alpha was slightly increased.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahnfelt-Rønne I., Arrigoni-Martelli E. Multiple effects of a new anti-inflammatory agent, timegadine, on arachidonic acid release and metabolism in neutrophils and platelets. Biochem Pharmacol. 1982 Aug 15;31(16):2619–2624. doi: 10.1016/0006-2952(82)90708-0. [DOI] [PubMed] [Google Scholar]
- Glenn E. M., Bowman B. J., Rohloff N. A. Anomalous biological effects of salicylates and prostaglandins. Agents Actions. 1979 Aug;9(3):257–264. doi: 10.1007/BF01966698. [DOI] [PubMed] [Google Scholar]
- Jones T. R., Young R., Champion E., Charette L., Denis D., Ford-Hutchinson A. W., Frenette R., Gauthier J. Y., Guindon Y., Kakushima M. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Can J Physiol Pharmacol. 1986 Aug;64(8):1068–1075. doi: 10.1139/y86-183. [DOI] [PubMed] [Google Scholar]
- Lange K., Peskar B. A., Peskar B. M. Stimulation of rat gastric mucosal leukotriene C4 formation by ethanol and effect of gastric protective drugs. Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:299–302. [PubMed] [Google Scholar]
- Peskar B. M., Lange K., Hoppe U., Peskar B. A. Ethanol stimulates formation of leukotriene C4 in rat gastric mucosa. Prostaglandins. 1986 Feb;31(2):283–293. doi: 10.1016/0090-6980(86)90054-7. [DOI] [PubMed] [Google Scholar]
- Robert A. Gastric cytoprotection by sodium salicylate. Prostaglandins. 1981;21 (Suppl):139–146. doi: 10.1016/0090-6980(81)90130-1. [DOI] [PubMed] [Google Scholar]
- Wallace J. L., Whittle B. J. Role of prostanoids in the protective actions of BW755C on the gastric mucosa. Eur J Pharmacol. 1985 Sep 10;115(1):45–52. doi: 10.1016/0014-2999(85)90582-5. [DOI] [PubMed] [Google Scholar]
- Whittle B. J., Higgs G. A., Eakins K. E., Moncada S., Vane J. R. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature. 1980 Mar 20;284(5753):271–273. doi: 10.1038/284271a0. [DOI] [PubMed] [Google Scholar]